Aktie A3EJ05 CHARMACY PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Charmacy Pharmaceutical Co., Ltd.

Aktien

A3EJ05

CNE1000023D6

2289

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:20 26.04.2024 		% 5 Tage % 1. Jan.
13.94 HKD -0.29% Intraday Chart für Charmacy Pharmaceutical Co., Ltd. +39.68% +7.56%
28.03. Charmacy Pharmaceutical Co. Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
18.03. Gewinn von Charmacy Pharmaceutical wird 2023 um 45% sinken MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023
Charmacy Pharmaceutical Meets Minimum Public Float Norms
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023
Charmacy Pharmaceutical Chairman Steps Down
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EJ05 Aktie
  4. Nachrichten Charmacy Pharmaceutical Co., Ltd.
  5. Andere Sprachen